Cargando…

PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value

BACKGROUND: The effects of PIM-1 on the progression of pancreatic cancer remain unclear, and the prognostic value of PIM-1 levels in tissues is controversial. Additionally, the expression levels and clinical value of PIM-1 in plasma have not been reported. METHODS: The effects of PIM-1 on biological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jianwei, Xiong, Guangbing, Cao, Zhe, Huang, Hua, Wang, Tianxiao, You, Lei, Zhou, Li, Zheng, Lianfang, Hu, Ya, Zhang, Taiping, Zhao, Yupei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011911/ https://www.ncbi.nlm.nih.gov/pubmed/27596051 http://dx.doi.org/10.1186/s13046-016-0406-z

Ejemplares similares

MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis
por: Xu, Jianwei, et al.
Publicado: (2014)

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
por: Feng, Mengyu, et al.
Publicado: (2018)

MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Xiong, Guangbing, et al.
Publicado: (2018)

Correction to: MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma
por: Xiong, Guangbing, et al.
Publicado: (2021)

Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer
por: Xiong, Guangbing, et al.
Publicado: (2019)

MiR-1178 Promotes the Proliferation, G1/S Transition, Migration and Invasion of Pancreatic Cancer Cells by Targeting CHIP
por: Cao, Zhe, et al.
Publicado: (2015)

CHIP: A new modulator of human malignant disorders
por: Cao, Zhe, et al.
Publicado: (2016)

miR-497 expression, function and clinical application in cancer
por: Yang, Gang, et al.
Publicado: (2016)

Clinical characteristics and prognosis of primary leiomyosarcoma of the pancreas: a systematic review
por: Xu, Jianwei, et al.
Publicado: (2013)

Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
por: Qiu, Jiangdong, et al.
Publicado: (2018)

CHIP is a novel tumor suppressor in pancreatic cancer and inhibits tumor growth through targeting EGFR
por: Wang, Tianxiao, et al.
Publicado: (2014)

Role of the microbiome in occurrence, development and treatment of pancreatic cancer
por: Wang, Yicheng, et al.
Publicado: (2019)

Localized Autoimmune Pancreatitis: Report of a Case Clinically Mimicking Pancreatic Cancer and a Literature Review
por: Cao, Zhe, et al.
Publicado: (2015)

Targeting hypoxic tumor microenvironment in pancreatic cancer
por: Tao, Jinxin, et al.
Publicado: (2021)

Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
por: Luo, Wenhao, et al.
Publicado: (2019)

Pancreatic panniculitis associated with pancreatic carcinoma: A case report
por: Zhang, Guannan, et al.
Publicado: (2016)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
por: Yu, Yiqi, et al.
Publicado: (2021)

Pancreatic head cancer: Open or minimally invasive pancreaticoduodenectomy?
por: Feng, Mengyu, et al.
Publicado: (2019)

Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm
por: Cui, Ming, et al.
Publicado: (2023)

MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
por: Cao, Zhe, et al.
Publicado: (2020)

Current epidemiology of pancreatic cancer: Challenges and opportunities
por: Luo, Wenhao, et al.
Publicado: (2020)

Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer
por: Wu, Mengwei, et al.
Publicado: (2019)

Analysis of clinical characteristics and treatment of pancreatic cystic tumors
por: You, Lei, et al.
Publicado: (2016)

Novel Discoveries Targeting Pathogenic Gut Microbes and New Therapies in Pancreatic Cancer: Does Pathogenic E. coli Infection Cause Pancreatic Cancer Progression Modulated by TUBB/Rho/ROCK Signaling Pathway? A Bioinformatic Analysis
por: Luo, Wenhao, et al.
Publicado: (2020)

Expression, function and clinical application of stanniocalcin‐1 in cancer
por: Zhao, Fangyu, et al.
Publicado: (2020)

Novel therapies targeting hypoxia mechanism to treat pancreatic cancer
por: Luo, Wenhao, et al.
Publicado: (2021)

Comparison of long-term benefits of organ-preserving pancreatectomy techniques for benign or low-grade malignant tumors at the pancreatic head
por: Li, Yatong, et al.
Publicado: (2017)

Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study
por: Cao, Zhe, et al.
Publicado: (2016)

Is Invagination Anastomosis More Effective in Reducing Clinically Relevant Pancreatic Fistula for Soft Pancreas After Pancreaticoduodenectomy Under Novel Fistula Criteria: A Systematic Review and Meta-Analysis
por: Cao, Zhe, et al.
Publicado: (2020)

Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2021)

A novel prognostic marker and immunogenic membrane antigen: prohibitin (PHB) in pancreatic cancer
por: Wang, Weibin, et al.
Publicado: (2018)

A Single Talent Immunogenic Membrane Antigen and Novel Prognostic Predictor: voltage-dependent anion channel 1 (VDAC1) in Pancreatic Cancer
por: Wang, Weibin, et al.
Publicado: (2016)

Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory
por: Luo, Wenhao, et al.
Publicado: (2020)

Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma
por: He, Jingyi, et al.
Publicado: (2020)

Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2022)

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
por: Fu, Yibo, et al.
Publicado: (2021)

MicroRNA-381—A Key Transcriptional Regulator: Its Biological Function and Clinical Application Prospects in Cancer
por: Zeng, Xue, et al.
Publicado: (2020)

MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations
por: Zhang, Jingcheng, et al.
Publicado: (2019)

The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star
por: Zhu, Ruizhe, et al.
Publicado: (2020)

Management of late hemorrhage after pancreatic surgery: treatment strategy and prognosis
por: Wu, Xin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i1n1tlmhc02jv519t9anvnqgmt